Professor Jason Tydin

speaker

44 appearances 1 recordings 1 series first heard Jul 2026 last heard 3 Jul

Professor Jason Tydin’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment

Health Report · Could a sleep supplement help reduce chronic pain? · 3 Jul 2026 podcast

It tells us that there are fundamental differences in how the immune system works in people with celiac disease compared to people without the disease.

There may be a way that we can measure immune cells from a person and see if they've changed and behave differently that puts them at higher risk of developing celiac disease.

And as a clinician, what we really want to know in patients is whether they might be at risk of developing the condition.

And that's really a big question for many people who have children and they might have celiac disease and could their child develop it.

And I hope that this information will allow us to develop better ways to predict the risk of someone going on to develop celiac disease.

And this could apply to other autoimmune diseases as well.

So there's the potential for very broad implications in understanding autoimmune disease risk.

For people diagnosed with celiac disease, there's a number of issues that they can face, including the need for a lifelong and strict gluten-free diet, which is quite onerous.

It's costly.

It impacts quality of life and lifestyle.

So there is a real need that we see for better options to help people.

And the exciting thing is that particularly in the last few years, there's been a real

increase in the number of clinical studies testing new therapeutic approaches.

And that includes approaches that try to reset the immune system to tolerize it to gluten so that people can have gluten in their diet again.

Other approaches that block that immune response against gluten so that it doesn't cause the damage in the bowels or the symptoms people can get.

And even approaches that try to degrade or

break down gluten to minimize contamination.

So nothing yet has been approved, but there's some really exciting results coming out.

Where I work at the Royal Melbourne Hospital, there's several clinical trials that people can get involved in.

So the hope is that in the future, there will be better options that people can access to help their treatment.

Showing 21–40 of 44 · page 2 of 3